Comparison of Triflusal and Clopidogrel in Secondary Prevention of Stroke Based on the Genotyping (MAESTRO)

This study has been completed.
Sponsor:
Collaborators:
Myung In Pharmaceutical Company
Yonsei University
Information provided by (Responsible Party):
KyungYul Lee, Gangnam Severance Hospital
ClinicalTrials.gov Identifier:
NCT01174693
First received: August 3, 2010
Last updated: March 16, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2015
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)